tetramethylpyrazine has been researched along with Kidney Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jia, H; Kong, F; Liu, J; Liu, L; Liu, X; Luan, Y; Sun, C; Wang, J; Xue, X | 1 |
1 other study(ies) available for tetramethylpyrazine and Kidney Neoplasms
| Article | Year |
|---|---|
Tetramethypyrazine inhibits renal cell carcinoma cells through inhibition of NKG2D signaling pathways.
Topics: Blotting, Western; Carcinoma, Renal Cell; Cell Proliferation; Cell Survival; Flow Cytometry; Fluorescent Antibody Technique; Gene Expression Regulation, Neoplastic; Humans; Kidney Neoplasms; NK Cell Lectin-Like Receptor Subfamily K; Pyrazines; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Tumor Cells, Cultured; Vasodilator Agents | 2016 |